Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 209, Issue 1-2, 2003, Pages 93-99

  Nguyen, Linh T ^a   Ramanathan, Murali ^a   Weinstock Guttman, Bianca ^b   Baier, Monika ^c   Brownscheidle, Carol ^b   Jacobs, Lawrence D ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c Cooper Institute ^*  (United States)

Author keywords

Flow cytometry; Interferon gamma; Multiple sclerosis; Sexual dimorphism; Tumor necrosis factor alpha

Indexed keywords

ANTIBODY; BREFELDIN A; CANCER GROWTH FACTOR; CD3 ANTIGEN; GAMMA INTERFERON; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISABILITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; T LYMPHOCYTE;

EID: 0037447796     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00004-2     Document Type: Article

References (28)

1. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science. 283(5406):1999;1277-1278.
2. Duquette P., Pleines J., Girard M., Charest L., Senecal-Quevillon M., Masse C. The increased susceptibility of women to multiple sclerosis. [Review, 74 refs.] Can. J. Neurol. Sci. 19(4):1992;466-471.
3. Duquette P., Girard M. Hormonal factors in susceptibility to multiple sclerosis. [Review, 28 refs.] Curr. Opin. Neurol. Neurosurg. 6(2):1993;195-201.
4. Korn-Lubetzki I., Kahana E., Cooper G., Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann. Neurol. 16(2):1984;229-231.
5. Birk K., Ford C., Smeltzer S., Ryan D., Miller R., Rudick R.A. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol. 47(7):1990;738-742.
6. Zorgdrager A., De Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J. Neurol. Sci. 149(1):1997;95-97.
7. Compston A. The genetic epidemiology of multiple sclerosis. Philos. Trans. R. Soc. Lond., B Biol. Sci. 354(1390):1999;1623-1634.
8. Raine C.S. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. [Review, 50 refs.] Ann. Neurol. 36(Supplement):1994;S61-S72.
9. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J. Neuroimmunol. 4(3):1983;201-221.
10. Benveniste E.N., Sparacio S.M., Bethea J.R. Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes. J. Neuroimmunol. 25(2-3):1989;209-219.
11. Trotter J.L., Clifford D.B., McInnis J.E., Griffeth R.C., Bruns K.A., Perlmutter M.S.et al. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis. Ann. Neurol. 25(2):1989;172-178.
12. Trotter J.L., Collins K.G., van der Veen R.C. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels. J. Neuroimmunol. 33(1):1991;29-36.
13. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., Weiner H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U. S. A. 94(2):1997;599-603.
14. Balashov K.E., Comabella M., Ohashi T., Khoury S.J., Weiner H.L. Defective regulation of IFN gamma and IL-12 by endogenous IL-10 in progressive MS. Neurology. 55(2):2000;192-198.
15. Duran I., Martinez-Caceres E.M., Brieva L., Tintore M., Montalban X. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis. Mult. Scler. 7(3):2001;151-156.
16. Killestein J., Den Drijver B.F., Van der Graaff W.L., Uitdehaag B.M., Polman C.H., Van Lier R.A. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease. Mult. Scler. 7(3):2001;145-150.
17. Petereit H.F., Richter N., Pukrop R., Bamborschke S. Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients. Mult. Scler. 6(1):2000;19-23.
18. Pelfrey C., Cotleur A., Lee J., Rudick R. Sex differences in cytokine responses to myelin peptides in multiple sclerosis. J. Neuroimmunol. 130(1-2):2002;211.
19. Marzi M., Vigano A., Trabattoni D., Villa M.L., Salvaggio A., Clerici E.et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106(1):1996;127-133.
20. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today. 18(10):1997;478-482.
21. Raghupathy R. Maternal anti-placental cell-mediated reactivity and spontaneous abortions. Am. J. Reprod. Immunol. 37(6):1997;478-484.
22. Hill J.A. T-helper 1-type immunity to trophoblast: evidence for a new immunological mechanism for recurrent abortion in women. Hum. Reprod. 10(Suppl. 2):1995;114-120.
23. Hill J.A., Polgar K., Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA. 273(24):1995;1933-1936.
24. Elenkov I.J., Wilder R.L., Bakalov V.K., Link A.A., Dimitrov M.A., Fisher S.et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 86(10):2001;4933-4938.
25. Butterfield R.J., Blankenhorn E.P., Roper R.J., Zachary J.F., Doerge R.W., Sudweeks J.et al. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 162(5):1999;3096-3102.
26. Bebo B.F. Jr., Schuster J.C., Vandenbark A.A., Offner H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162(1):1999;35-40.
27. Liva S.M., Voskuhl R.R. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167(4):2001;2060-2067.
28. Dalal M., Kim S., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159(1):1997;3-6.